Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch
Go back to Denali Therapeutics outlines 2026 milestones including Hunter syndrome launch| (NASDAQ: DNLI) | Delayed: 24.15 -0.77 (3.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.92 | 52 Week High | $ | |||
| Open | $25.27 | 52 Week Low | $ | |||
| Day High | $25.27 | P/E | N/A | |||
| Day Low | $24.00 | EPS | $ | |||
| Volume | 169,566 | |||||

